Post-operative adjuvant therapy for resectable patients with node positive oesophageal cancer Annual Meeting GI 2016

Daniel Catenacci, MD of The University of Chicago Medicine discusses post-operative adjuvant therapy for resectable patients with node positive esophageal cancer at ASCO GI 2016